Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

about

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

Item

http://www.wikidata.org/entity/Q47833921

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@en

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@nl

type

Item

label

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@en

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@nl

prefLabel

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@en

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

@nl

P1476

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke

@en

P2093

Ellisiv B Mathiesen

http://www.w3.org/2001/XMLSchema#string

Erin M Hald

http://www.w3.org/2001/XMLSchema#string

Inger Njølstad

http://www.w3.org/2001/XMLSchema#string

John-Bjarne Hansen

http://www.w3.org/2001/XMLSchema#string

Sigrid K Brækkan

http://www.w3.org/2001/XMLSchema#string

Tom Wilsgaard

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic treatment of atrial fibrillation in hospital

What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Venous thromboembolism after acute stroke.

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based h

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.

P31

scholarly article

P356

10.1161/JAHA.117.006502

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maja-Lisa Løchen

Ludvig B Rinde

P577

2018-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29378729

http://www.w3.org/2001/XMLSchema#string

P932

5850231

http://www.w3.org/2001/XMLSchema#string